Drug Development Strategy in the United States: An Industrial View of DMPK

Authors

Joseph W. Polli ViiV Healthcare, Five Moore Drive, Research Triangle Park (RTP), NC 27709-3398 USA https://orcid.org/0000-0003-3812-8985

DOI:

https://doi.org/10.33892/aph.2021.91.103-105

Keywords:

Metabolism, discovery, pharmacokinetics, machine learning, toxicology

PDF for Polli, APH 2021;91:103-105

Published

2021-11-15

How to Cite

(1)

Polli, J. W. . Drug Development Strategy in the United States: An Industrial View of DMPK. Acta Pharm Hung 2021, 91, 103-105.

Download Citation

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.